Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Research & Development: 2012-2024

Historic Research & Development for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $73.9 million.

  • Amphastar Pharmaceuticals' Research & Development rose 6.06% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 million, marking a year-over-year increase of 5.88%. This contributed to the annual value of $73.9 million for FY2024, which is 0.23% up from last year.
  • Amphastar Pharmaceuticals' Research & Development amounted to $73.9 million in FY2024, which was up 0.23% from $73.7 million recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Research & Development registered a high of $74.8 million during FY2022, and its lowest value of $60.9 million during FY2021.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Research & Development value was $73.9 million (recorded in 2024), while the average stood at $74.1 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Research & Development dropped by 9.37% in 2021 and then rose by 22.71% in 2022.
  • Over the past 5 years, Amphastar Pharmaceuticals' Research & Development (Yearly) stood at $67.2 million in 2020, then dropped by 9.37% to $60.9 million in 2021, then grew by 22.71% to $74.8 million in 2022, then declined by 1.38% to $73.7 million in 2023, then climbed by 0.23% to $73.9 million in 2024.